Correlation Between Y MAbs and DiaMedica Therapeutics
Can any of the company-specific risk be diversified away by investing in both Y MAbs and DiaMedica Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Y MAbs and DiaMedica Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Y mAbs Therapeutics and DiaMedica Therapeutics, you can compare the effects of market volatilities on Y MAbs and DiaMedica Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Y MAbs with a short position of DiaMedica Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Y MAbs and DiaMedica Therapeutics.
Diversification Opportunities for Y MAbs and DiaMedica Therapeutics
-0.18 | Correlation Coefficient |
Good diversification
The 3 months correlation between YMAB and DiaMedica is -0.18. Overlapping area represents the amount of risk that can be diversified away by holding Y mAbs Therapeutics and DiaMedica Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on DiaMedica Therapeutics and Y MAbs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Y mAbs Therapeutics are associated (or correlated) with DiaMedica Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of DiaMedica Therapeutics has no effect on the direction of Y MAbs i.e., Y MAbs and DiaMedica Therapeutics go up and down completely randomly.
Pair Corralation between Y MAbs and DiaMedica Therapeutics
Given the investment horizon of 90 days Y mAbs Therapeutics is expected to under-perform the DiaMedica Therapeutics. In addition to that, Y MAbs is 1.1 times more volatile than DiaMedica Therapeutics. It trades about -0.2 of its total potential returns per unit of risk. DiaMedica Therapeutics is currently generating about 0.29 per unit of volatility. If you would invest 443.00 in DiaMedica Therapeutics on September 3, 2024 and sell it today you would earn a total of 123.00 from holding DiaMedica Therapeutics or generate 27.77% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Y mAbs Therapeutics vs. DiaMedica Therapeutics
Performance |
| Timeline |
| Y mAbs Therapeutics |
| DiaMedica Therapeutics |
Y MAbs and DiaMedica Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Y MAbs and DiaMedica Therapeutics
The main advantage of trading using opposite Y MAbs and DiaMedica Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Y MAbs position performs unexpectedly, DiaMedica Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DiaMedica Therapeutics will offset losses from the drop in DiaMedica Therapeutics' long position.| Y MAbs vs. DiaMedica Therapeutics | Y MAbs vs. Lyra Therapeutics | Y MAbs vs. Centessa Pharmaceuticals PLC |
| DiaMedica Therapeutics vs. Milestone Pharmaceuticals | DiaMedica Therapeutics vs. Seres Therapeutics | DiaMedica Therapeutics vs. Inhibikase Therapeutics | DiaMedica Therapeutics vs. Oncolytics Biotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Complementary Tools
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Stocks Directory Find actively traded stocks across global markets | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |